The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly

scientific article

The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P6179Dimensions Publication ID1042693136
P356DOI10.2165/00003088-198712020-00002
P698PubMed publication ID3549104

P2093author name stringK W Woodhouse
H Wynne
P2860cites workSalicylate accumulation kinetics in manQ28249630
Diflunisal: a review of pharmacokinetic and pharmacodynamic properties, drug interactions, and special tolerability studies in humansQ28294653
Non-oliguric renal failure during treatment with mefenamic acid in elderly patients: a continuing problemQ28362367
Pharmacokinetics of ketoprofen in the elderlyQ34512945
The effect of ageing on the hepatic clearance of propranololQ34517399
Aspirin metabolism and efficacy in postoperative dental painQ34621226
Naproxen pharmacokinetics in the elderlyQ34621473
The disposition of sulindacQ34684315
Effects of age and disease on the pharmacokinetics and pharmacodynamics of sulindacQ34695329
Benoxaprofen: side-effect profile in 300 patients.Q34759595
Fatal cholestatic jaundice in elderly patients taking benoxaprofen.Q34759664
The pharmacology of benoxaprofen (2-[4-chlorophenyl]-α-methyl-5-benzoxazole acetic acid), LRCL 3794, a new compound with anti-inflammatory activity apparently unrelated to inhibition of prostaglandin synthesisQ39156132
Drugs and the ageing gut, liver and pancreasQ39415334
Piroxicam Pharmacokinetics in Man: Aspirin and Antacid Interaction StudiesQ39558510
Clinical Pharmacokinetics of indomethacinQ39567269
Pharmacokinetics and Metabolism of the Anti-Inflammatory Agent VoltarenQ39615797
Comparative disposition of sulindac and metabolites in five speciesQ39638427
Clinical Pharmacokinetics of PhenylbutazoneQ39773902
Clinical significance of esterases in man.Q39829565
Alterations in the liver with ageing.Q39839015
Ibuprofen: a review of its pharmacological properties and therapeutic efficacy in rheumatic disordersQ40006961
Clinical Pharmacokinetics of Non-steroidal Anti-inflammatory DrugsQ40157661
Sulindac: therapeutic implications of the prodrug/pharmacophore equilibriumQ40327847
Defective oxidation of drugs: pharmacokinetic and therapeutic implicationsQ40329696
Preliminary studies of absorption and excretion of benoxaprofen in manQ40659320
Disposition and Metabolism of Benoxaprofen in Laboratory Animals and ManQ41416983
Pharmacokinetics of Salicylates in ElderlyQ41494121
The influence of age on the pharmacokinetics of paracetamol [proceedings]Q41606702
Digoxin in the elderly: Pharmacokinetic consequences of old ageQ41617375
Reduced elimination of ketoprofen in the elderly is not necessarily due to impaired glucuronidationQ41861859
Transsynovial distribution of ibuprofen in arthritic patientsQ42274287
Pharmacokinetics of indomethacinQ42597265
Ketoprofen pharmacokinetics and bioavailability based on an improved sensitive and specific assayQ42671028
Pharmacokinetics of azapropazone in the elderlyQ42739047
The effect of vitamin supplementation upon antipyrine metabolism in the elderlyQ43251770
Pharmacokinetic observations on piroxicam in young adult, middle-aged and elderly patientsQ43261977
Nonlinear plasma level response to high doses of naproxenQ47886452
Effect of Age and Sex on Human Drug MetabolismQ50348052
Pharmacokinetic studies of benoxaprofen in geriatric patients.Q51652496
The influence of food on the absorption of diclofenac as determined by the urinary excretion of the unchanged drug and its major metabolites during chronic administration.Q51655959
Biopharmaceutical assessment of phenylbutazone and indomethacin preparations.Q53761127
The binding of indomethacin, salicylate and phenobarbitone to human whole blood in vitro.Q54586946
The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material.Q54797299
Effects of aspirin and acetaminophen in gastrointestinal hemorrhage. Results from the Boston Collaborative Drug Surveillance ProgramQ57946016
Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver diseaseQ59525256
Factors affecting the pharmacokinetics of diclofenac sodium (Voltarol)Q66987957
Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smokingQ67273626
Naproxen-metabolism, excretion and comparative pharmacokineticsQ67273846
Absorption kinetics of aspirin in man following oral administration of an aqueous solutionQ67300357
Pharmacokinetics in the elderlyQ67396499
Aging and ethanol metabolismQ67548911
Disposition of pirprofen, a new anti-inflammatory drugQ67575105
Disposition and oxidative metabolism of phenylbutazone in manQ67594631
The effect of ageing on drug absorption from the gutQ67669312
Protein binding of indomethacin: binding of indomethacin to human plasma albumin and its displacement from binding by ibuprofen, phenylbutazone and salicylate, in vitroQ68803909
The metabolism of indomethacin in manQ69180079
Aging, Total Body Potassium, Fat-free Mass, and Cell Mass in Males and Females Between Ages 18 and 85 YearsQ69377354
Naproxen Oral Absorption CharacteristicsQ69391961
Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia StudyQ69596139
Pharmacokinetics of pirprofen in young volunteers and elderly patientsQ69874385
Non-steroidal anti-inflammatory drugs and bleeding peptic ulcerQ69877679
Rising frequency of ulcer perforation in elderly people in the United KingdomQ69877701
The effect of age on pathways of drug metabolism in human liverQ70231205
Sulindac disposition when given once and twice dailyQ70252808
Non-steroidal anti-inflammatory drugs and serious gastrointestinal adverse reactions--2Q70288264
The pharmacokinetics of benoxaprofen in elderly subjectsQ70369735
Absorption and disposition of ibuprofen in the elderlyQ70612534
Vancomycin disposition: the importance of ageQ70670631
The effect of alcoholic cirrhosis on the two kinetic components (high and low affinity) of the microsomal 0-deethylation of 7-ethoxycoumarin in human liverQ71006211
Gastrointestinal and liver function of old ageQ71032820
Haematological and biochemical laboratory values in an ambulatory elderly population: an analysis of the effects of age, sex and drugsQ71160662
Pharmacokinetics of ketoprofen following single oral, intramuscular and rectal doses and after repeated oral administrationQ71397265
Pharmacokinetics of metoprolol and its metabolite alpha-OH-metoprolol in healthy, non-smoking, elderly individualsQ71705871
Drug distribution and renal excretion in the elderlyQ71728184
Increased serum salicylate metabolites with age in patients receiving chronic acetylsalicylic acid therapyQ72098454
Capacity-Limited Salicylurate Formation During Prolonged Administration of Aspirin to Healthy Human SubjectsQ72394299
Metabolism of piroxicam by laboratory animalsQ72475136
Jaundice associated with the use of benoxaprofenQ72526111
Gastric and duodenal ulcer. The association between aspirin ingestion, smoking and family history of ulcerQ72532420
Metabolism of pirprofen in man, monkey, rat, and mouseQ72539175
Comparative steady state pharmacokinetic study of piroxicam and flurbiprofen in normal subjectsQ72841712
Age differences in the water content of the body as related to basal oxygen consumption in malesQ79666551
Salicylate kinetics in old ageQ93571509
P433issue2
P921main subjectpharmacokineticsQ323936
inflammationQ101991
P304page(s)111-122
P577publication date1987-02-01
P1433published inClinical PharmacokineticsQ5133788
P1476titleThe pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly
P478volume12

Reverse relations

cites work (P2860)
Q36485541Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics
Q34512204Articular diffusion of meloxicam after a single oral dose: relationship to cyclo-oxygenase inhibition in synovial cells
Q33937522Choosing the right nonsteroidal anti-inflammatory drug for the right patient: a pharmacokinetic approach
Q45280007Clearance of indomethacin occurs predominantly by renal glucuronidation
Q34311477Cox-2 inhibitors and other nonsteroidal anti-inflammatory drugs in the treatment of pain in the elderly
Q44614902Disposition of flurbiprofen in man: influence of stereochemistry and age
Q35170409Do the pharmacodynamics of the nonsteroidal anti-inflammatory drugs suggest a role in the management of postoperative pain?
Q39522004Drug metabolism in the elderly
Q69665194Effect of age on the pharmacokinetics of dipyrone
Q36724175Elderly people taking non-steroidal anti-inflammatory drugs are unlikely to have excess renal impairment
Q34531655Influence of age and cytochrome P450 2C9 genotype on the steady-state disposition of diclofenac and celecoxib
Q35825392Influence of age on the enantiomeric disposition of ibuprofen in healthy volunteers
Q36282905Non-steroidal Anti-inflammatory Drugs: Monitoring to help prevent serious adverse effects
Q68506534Nonsteroidal anti-inflammatory drugs
Q36122786Nonsteroidal anti-inflammatory drugs alter vasa recta diameter via pericytes
Q50960420Oxaprozin and piroxicam, nonsteroidal antiinflammatory drugs with long half-lives: effect of protein-binding differences on steady-state pharmacokinetics.
Q34171491Pain in nursing home residents: management strategies
Q36148700Pain management for dentists: the role of ibuprofen.
Q40425454Pharmacokinetic Optimisation of Drug Therapy in Elderly Patients
Q40758038Pharmacokinetic optimisation of the treatment of osteoarthritis
Q35277247Pharmacokinetics and dose proportionality of cefmetazole in healthy young and elderly volunteers
Q70743653Pharmacokinetics of indomethacin in the elderly
Q68057834Pharmacokinetics of pirazolac, a new anti-inflammatory drug, in human volunteers. III. Steady state plasma levels
Q34358409Pharmacokinetics of the anti-inflammatory drug ximoprofen in healthy young and elderly subjects: comparison with elderly rheumatic patients
Q77733092Renal hemodynamic effects of nabumetone, sulindac, and placebo in patients with osteoarthritis
Q40919271Selective inhibitors of cyclooxygenase-2. Potential in elderly patients
Q33973162Systematic review: is the use of NSAIDs effective and safe in the elderly?
Q36972832The Problems and Pitfalls of NSAID Therapy in the Elderly (Part II)1
Q34345908The pharmacokinetics of piroxicam in elderly persons with and without renal impairment
Q41526041Toxicity of Nonsteroidal Anti-Inflammatory Drugs in the Elderly: Is Advanced Age a Risk Factor?
Q67834984Unaltered ibuprofen-induced faecal blood loss upon coadministration of moclobemide